从Pseudognaphalium liebmannii中分离的黄具有气管平滑肌肉松性质
Andrés Navarrete1,2, José Luis Balderas-López1, José Guadalupe Rosas-Canales1
1Facultad de Química, Departamento de Farmacia, Universidad Nacional Autónoma de México, Ciudad Universitaria, Coyoacán, Ciudad de México, México.
Natural product research
|January 8, 2024
概括
来自Pseudognaphalium liebmannii的黄类化合物放松呼吸道光滑肌肉并抑制固酶 (PDE),支持其用于呼吸道疾病的传统用途.
科学领域:
- 植物化学 植物化学
- 药理学 药理学是指药理学的学科.
- 传统医学的传统医学.
背景情况:
- 传统上,Pseudognaphalium liebmannii的花朵用于呼吸系统疾病.
- 黄类是植物化合物的一类,具有多样化的生物活性.
研究的目的:
- 从P. liebmannii的花朵中分离和识别化合物.
- 评估分离化合物对呼吸道光滑肌肉的放松作用.
- 研究作用机制,包括固酶 (PDE) 抑制.
主要方法:
- 从P. liebmannii提取物中分离和描述七种已知的黄素.
- 在几内亚猪气管制剂中对呼吸道光滑肌肉放松的评估.
- 在体外酸酶 (PDE) 抑制试验.
- 对福斯科林和尼特罗普鲁塞德度-反应曲线的影响分析.
主要成果:
- 他们分离了七种类型的黄:5-基-3,7-二甲基黄 (1),5,8-二甲基-3,7-二甲基黄 (2),5,7-二甲基-3,8-二甲基黄 (3),3,5-二甲基-7,8-二甲基黄 (4),3,5-二甲基-6,7,8-三甲基黄 (5),3,5,7-三甲基黄 (6),以及3-O-甲基基 (7).
- 黄2,3,4,5和7对几内亚猪气管制剂表现出显著的放松作用.
- 这些活性黄在体外显示了对固酶 (PDE) 的剂量依赖性抑制.
- 黄改变了福斯科林和尼托普鲁塞德的度-反应曲线,表明它调节了参与平滑肌肉放松的信号通路.
结论:
- 利伯曼尼的花朵含有具有显著的呼吸道平滑肌肉松性质的黄.
- 固酶 (PDE) 抑制是促进观察到的放松作用的关键机制.
- 这些发现为P. liebmannii在治疗喘等呼吸道疾病的传统用途提供了科学验证.
相关概念视频
Skeletal Muscle Relaxants: Therapeutic Uses
487
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
487
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
978
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
978
Direct-Acting Cholinergic Agonists: Pharmacological Actions
1.3K
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
1.3K
Nitric Oxide Signaling Pathway
5.0K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.0K
Cholinergic Antagonists: Pharmacological Actions
1.1K
Antimuscarinic drugs block muscarinic receptors in multiple systems, including the gut, eye, smooth muscles, respiratory tract, cardiovascular, and central nervous systems. They produce similar effects with varying selectivity depending on the specific agent and tissue. Here are the key pharmacological actions of antimuscarinics:
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
1.1K
Cholinergic Antagonists: Therapeutic Uses
749
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
749


